TrialInternational journal of cancer2026

Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial.

Oscar Danielsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.